UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Allogeneic bone marrow transplantation in aggressive non‐Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database

British journal of haematology, 1999-10, Vol.107 (1), p.154-161

1999

Volltextzugriff (PDF)

Tumor flare reaction in a patient with mycosis fungoides treated with a novel immune-epigenetic doublet

JAAD Case Reports, 2024-06, Vol.48, p.18-22

2024

Volltextzugriff (PDF)

Phase I study of novel SYK inhibitor TAK‐659 (mivavotinib) in combination with R‐CHOP for front‐line treatment of high‐risk diffuse large B‐cell lymphoma

EJHaem, 2023-02, Vol.4 (1), p.108-114

2023

Volltextzugriff (PDF)

EXABS-140-LYM High Grade B-Cell Lymphoma: Pathologic Classification and Treatment Recommendations

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S54-S56

2023

Volltextzugriff (PDF)

CyclOBEAP (cyclophosphamide, vincristine, bleomycin, etoposide, doxorubicin, prednisolone) regimen with granulocyte colony-stimulating factor (G-CSF) for patients with aggressive non-Hodgkin's lymphoma: a pilot study

European journal of haematology, 2000-09, Vol.65 (3), p.188-194

2000

Volltextzugriff (PDF)

The SYK inhibitor: a novel agent for improved outcomes in relapsed/refractory diffuse large B-cell lymphoma

Future oncology (London, England), 2023-04, Vol.19 (11), p.737-738

2023

Volltextzugriff (PDF)

Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphoma

Experimental hematology & oncology, 2015-07, Vol.4 (1), p.18, Article 18

2015

Volltextzugriff (PDF)

A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma

Leukemia & lymphoma, 2019-03, Vol.60 (4), p.904-911

2019

Volltextzugriff (PDF)

Tumor suppressors BTG1 and BTG2 regulate early mouse B-cell development

Haematologica (Roma), 2016-07, Vol.101 (7), p.e272-e276

2016

Volltextzugriff (PDF)

Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al

Haematologica (Roma), 2016-06, Vol.101 (6), p.e269-e270

2016

Volltextzugriff (PDF)

The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients

Cancers, 2022-03, Vol.14 (6), p.1569

2022

Volltextzugriff (PDF)

Author reply to Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al

Haematologica (Roma), 2016-06, Vol.101 (6), p.e271-e271

2016

Volltextzugriff (PDF)

Prognostication with circulating tumor DNA: is it ready for prime time?

Hematology, 2019-12, Vol.2019 (1), p.47-52

Kurtz, David M

2019

Volltextzugriff (PDF)

Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas

OncoTargets and therapy, 2014-01, Vol.7 (default), p.865-872

2014

Volltextzugriff (PDF)

Molecular profiling and management of mantle cell lymphoma

Hematology, 2019-12, Vol.2019 (1), p.30-40

Ruan, Jia

2019

Volltextzugriff (PDF)

Emerging strategies in peripheral T-cell lymphoma

Hematology, 2019-12, Vol.2019 (1), p.41-46

Mehta-Shah, Neha

2019

Volltextzugriff (PDF)

ABCL-719 Statewide Burden and Trend of Burkitt Lymphoma in the United States From 1990-2021: A Benchmarking Systematic Analysis for the Global Burden of Disease Study 2021

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S491-S492

2024

Volltextzugriff (PDF)

TCL-246 Peripheral T-Cell Lymphoma (PTCL) and treatment out-come Single centre retrospective study

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S522-S522

2024

Volltextzugriff (PDF)

Prognostic Impact of Baseline Immunologic Profile in Aggressive B-cell non-Hodgkin's Lymphomas

Mediterranean journal of hematology and infectious diseases, 2021-03, Vol.13 (1), p.e2021018-e2021018

2021

Volltextzugriff (PDF)

Pattern of Bone Marrow Involvement in B-cell Non-Hodgkin’s Lymphoma - Experience from a Tertiary Care Center in North India

Journal of radiation and cancer research, 2024-05, Vol.15 (2), p.64-68

2024

Volltextzugriff (PDF)

Treatment of aggressive B-cell non-Hodgkin lymphoma beyond frontline therapy in patients not eligible for stem cell transplantation: a structured review

Leukemia & lymphoma, 2019-06, Vol.60 (7), p.1610-1625

2019

Volltextzugriff (PDF)

Can we improve upon the International Index?

Annals of oncology, 1997, Vol.8 (suppl-1), p.S43-S47

Shipp, M.A.

1997

Volltextzugriff (PDF)

A prospective multicenter study investigating rituximab combined with intensive chemotherapy in newly diagnosed pediatric patients with aggressive mature B cell non-Hodgkin lymphoma (CCCG-BNHL-2015): a report from the Chinese Children’s Cancer Group

Annals of hematology, 2022-09, Vol.101 (9), p.2035-2043

2022

Volltextzugriff (PDF)

Keyword index

British journal of haematology, 2003-06, Vol.121 (6), p.962-965

2003

Volltextzugriff (PDF)

MACOP-B Chemotherapy for the Treatment of Aggressive Non Hodgkin's Lymphoma

Leukemia & lymphoma, 1992, Vol.6 (4-5), p.357-361

1992

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Clinical Lymphoma, Myeloma And Leukemia
(10)
Leukemia & Lymphoma
(4)
Haematologica
(3)
Hematology
(3)
Annals Of Hematology
(2)
British Journal Of Haematology
(2)
Cancers
(2)
Ejhaem
(2)
European Journal Of Haematology
(2)
Medicine
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Allogeneic bone marrow transplantation in aggressive non‐Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database

Tumor flare reaction in a patient with mycosis fungoides treated with a novel immune-epigenetic doublet

Phase I study of novel SYK inhibitor TAK‐659 (mivavotinib) in combination with R‐CHOP for front‐line treatment of high‐risk diffuse large B‐cell lymphoma

EXABS-140-LYM High Grade B-Cell Lymphoma: Pathologic Classification and Treatment Recommendations

CyclOBEAP (cyclophosphamide, vincristine, bleomycin, etoposide, doxorubicin, prednisolone) regimen with granulocyte colony-stimulating factor (G-CSF) for patients with aggressive non-Hodgkin's lymphoma: a pilot study

The SYK inhibitor: a novel agent for improved outcomes in relapsed/refractory diffuse large B-cell lymphoma

Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphoma

A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma

Tumor suppressors BTG1 and BTG2 regulate early mouse B-cell development

Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al

The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients

Author reply to Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al

Prognostication with circulating tumor DNA: is it ready for prime time?

Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas

Molecular profiling and management of mantle cell lymphoma

Emerging strategies in peripheral T-cell lymphoma

ABCL-719 Statewide Burden and Trend of Burkitt Lymphoma in the United States From 1990-2021: A Benchmarking Systematic Analysis for the Global Burden of Disease Study 2021

TCL-246 Peripheral T-Cell Lymphoma (PTCL) and treatment out-come Single centre retrospective study

Prognostic Impact of Baseline Immunologic Profile in Aggressive B-cell non-Hodgkin's Lymphomas

Pattern of Bone Marrow Involvement in B-cell Non-Hodgkin’s Lymphoma - Experience from a Tertiary Care Center in North India

Treatment of aggressive B-cell non-Hodgkin lymphoma beyond frontline therapy in patients not eligible for stem cell transplantation: a structured review

Can we improve upon the International Index?

A prospective multicenter study investigating rituximab combined with intensive chemotherapy in newly diagnosed pediatric patients with aggressive mature B cell non-Hodgkin lymphoma (CCCG-BNHL-2015): a report from the Chinese Children’s Cancer Group

Keyword index

MACOP-B Chemotherapy for the Treatment of Aggressive Non Hodgkin's Lymphoma

Aktive Filter

Suchergebnisse filtern